1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Bersch, B.
Hernandez, J.-F.
Marion, D.
Arlaud, G.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
37
1204
1214
10.1021/bi971851v
9477945
Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family.
1998
DK
J.Pept.Res.
JPERFA
2150
1397-002X
49
221
Chemical Synthesis and Characterization of the Egf-Like Module of Human Complement Protease C1R
1997
10.2210/pdb1apq/pdb
pdb_00001apq
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
CALCIUM-BINDING CONSENSUS SEQUENCE
5984.458
COMPLEMENT PROTEASE C1R
3.4.21.41
EGF-LIKE MODULE
1
man
polymer
no
no
AVDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDRHSCQAE
AVDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDRHSCQAE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1997-09-17
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
Y
BNL
1997-07-22
REL
REL
EXPERIMENTAL ENERGY
25
19
NOESY
6.7
288
K
REFINEMENT DETAILS CAN BE FOUND IN THE FOLLOWING JOURNAL CITATION : BLACKLEDGE ET AL., J. MOL. BIOL. 245, 661-681 (1995).
SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS
BIOSYM
refinement
DISCOVER (MODIFICATION OF ST
ST
structure solution
Discover
600
Bruker
AMX-600
ALA
23
n
1
ALA
23
A
VAL
24
n
2
VAL
24
A
ASP
25
n
3
ASP
25
A
LEU
26
n
4
LEU
26
A
ASP
27
n
5
ASP
27
A
GLU
28
n
6
GLU
28
A
CYS
29
n
7
CYS
29
A
ALA
30
n
8
ALA
30
A
SER
31
n
9
SER
31
A
ARG
32
n
10
ARG
32
A
SER
33
n
11
SER
33
A
LYS
34
n
12
LYS
34
A
SER
35
n
13
SER
35
A
GLY
36
n
14
GLY
36
A
GLU
37
n
15
GLU
37
A
GLU
38
n
16
GLU
38
A
ASP
39
n
17
ASP
39
A
PRO
40
n
18
PRO
40
A
GLN
41
n
19
GLN
41
A
PRO
42
n
20
PRO
42
A
GLN
43
n
21
GLN
43
A
CYS
44
n
22
CYS
44
A
GLN
45
n
23
GLN
45
A
HIS
46
n
24
HIS
46
A
LEU
47
n
25
LEU
47
A
CYS
48
n
26
CYS
48
A
HIS
49
n
27
HIS
49
A
ASN
50
n
28
ASN
50
A
TYR
51
n
29
TYR
51
A
VAL
52
n
30
VAL
52
A
GLY
53
n
31
GLY
53
A
GLY
54
n
32
GLY
54
A
TYR
55
n
33
TYR
55
A
PHE
56
n
34
PHE
56
A
CYS
57
n
35
CYS
57
A
SER
58
n
36
SER
58
A
CYS
59
n
37
CYS
59
A
ARG
60
n
38
ARG
60
A
PRO
61
n
39
PRO
61
A
GLY
62
n
40
GLY
62
A
TYR
63
n
41
TYR
63
A
GLU
64
n
42
GLU
64
A
LEU
65
n
43
LEU
65
A
GLN
66
n
44
GLN
66
A
GLU
67
n
45
GLU
67
A
ASP
68
n
46
ASP
68
A
ARG
69
n
47
ARG
69
A
HIS
70
n
48
HIS
70
A
SER
71
n
49
SER
71
A
CYS
72
n
50
CYS
72
A
GLN
73
n
51
GLN
73
A
ALA
74
n
52
ALA
74
A
GLU
75
n
53
GLU
75
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LEU
47
A
O
LEU
25
A
N
SER
58
A
N
SER
36
3
A
TYR
63
0.082
SIDE CHAIN
3
A
ARG
69
0.099
SIDE CHAIN
4
A
ARG
60
0.080
SIDE CHAIN
5
A
TYR
63
0.101
SIDE CHAIN
6
A
PHE
56
0.093
SIDE CHAIN
8
A
HIS
46
0.095
SIDE CHAIN
9
A
TYR
55
0.081
SIDE CHAIN
12
A
TYR
55
0.063
SIDE CHAIN
12
A
TYR
63
0.089
SIDE CHAIN
13
A
TYR
55
0.123
SIDE CHAIN
13
A
TYR
63
0.140
SIDE CHAIN
15
A
HIS
46
0.099
SIDE CHAIN
19
A
TYR
55
0.112
SIDE CHAIN
19
A
TYR
63
0.116
SIDE CHAIN
19
A
ARG
69
0.101
SIDE CHAIN
1
7.50
1.10
114.20
121.70
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
2
7.61
1.10
114.20
121.81
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
9
8.12
1.10
114.20
122.32
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
12
6.85
1.10
114.20
121.05
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
15
6.90
1.10
114.20
121.10
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
18
6.83
1.10
114.20
121.03
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
19
8.25
1.10
114.20
122.45
A
A
A
CA
CB
SG
CYS
CYS
CYS
48
48
48
N
1
A
SER
33
53.03
-149.18
1
A
ASP
39
-168.71
117.58
1
A
GLN
43
-59.33
102.96
1
A
CYS
44
73.61
53.63
1
A
HIS
46
-101.64
-83.58
1
A
PRO
61
-47.02
156.67
1
A
HIS
70
-158.21
-37.50
2
A
VAL
24
76.40
-56.77
2
A
LEU
26
-55.50
174.64
2
A
ASP
27
65.93
92.59
2
A
GLU
28
-153.07
-60.08
2
A
ARG
32
49.42
-110.84
2
A
LYS
34
67.95
-62.60
2
A
SER
35
-151.59
57.15
2
A
GLU
38
76.41
151.90
2
A
ASP
39
-154.85
75.78
2
A
PRO
42
-17.80
90.21
2
A
GLN
45
-6.97
-62.45
2
A
HIS
46
-88.00
-79.97
2
A
ARG
69
85.26
43.17
3
A
SER
35
28.62
65.93
3
A
GLU
37
66.45
-70.05
3
A
ASP
39
166.44
130.96
3
A
GLN
43
68.13
-1.10
3
A
GLN
45
-31.44
-85.66
3
A
HIS
46
-124.87
-72.89
3
A
PHE
56
-92.93
-72.04
3
A
CYS
57
104.34
167.36
3
A
HIS
70
-152.14
-27.41
4
A
GLU
28
-36.73
99.27
4
A
ALA
30
-120.48
-75.73
4
A
ARG
32
63.28
168.82
4
A
SER
35
-68.42
71.40
4
A
ASP
39
-155.54
-61.42
4
A
PRO
42
-54.95
170.93
4
A
GLN
43
-77.51
-111.31
4
A
CYS
44
156.16
164.19
4
A
HIS
46
-105.36
-94.12
5
A
GLU
28
-39.26
-36.12
5
A
SER
35
-150.33
-11.98
5
A
ASP
39
-166.20
92.16
5
A
GLN
43
-58.92
109.42
5
A
GLN
45
-60.44
-96.12
5
A
HIS
46
-83.46
-82.36
5
A
GLU
67
73.36
-52.00
5
A
ASP
68
114.13
-24.19
6
A
SER
33
-170.76
-63.15
6
A
LYS
34
-63.94
77.53
6
A
SER
35
-157.25
-68.90
6
A
ASP
39
71.81
80.93
6
A
HIS
46
-96.21
-75.19
6
A
PHE
56
-112.15
-77.66
6
A
CYS
57
97.03
166.70
6
A
HIS
70
-150.09
-45.43
7
A
GLN
43
-75.29
39.62
7
A
CYS
44
-178.16
135.42
7
A
HIS
46
-107.40
-90.58
7
A
TYR
51
-173.04
-174.55
7
A
ARG
69
75.05
-32.05
8
A
GLU
28
-60.49
70.88
8
A
CYS
29
-174.37
-63.59
8
A
LYS
34
61.91
60.53
8
A
ASP
39
71.71
107.46
8
A
PRO
42
-73.92
-167.68
8
A
HIS
46
-107.83
-76.60
8
A
TYR
51
-177.19
-178.72
8
A
GLU
67
-58.92
-0.70
8
A
ARG
69
72.66
-27.97
9
A
GLU
28
177.99
93.20
9
A
CYS
29
68.82
-64.00
9
A
GLU
38
-176.07
-169.75
9
A
HIS
46
-107.06
-84.74
9
A
ASP
68
-153.35
-14.56
9
A
ARG
69
73.67
-34.26
9
A
ALA
74
-86.31
45.10
10
A
ASP
25
108.52
161.83
10
A
ASP
27
-59.27
103.34
10
A
LYS
34
-64.34
78.54
10
A
SER
35
-156.68
47.57
10
A
GLU
37
-37.56
94.12
10
A
CYS
44
-59.45
101.62
10
A
HIS
46
-95.35
-82.63
10
A
HIS
70
-131.51
-42.92
11
A
LEU
26
44.52
-137.55
11
A
ASP
27
-100.84
73.32
11
A
ARG
32
47.39
-62.02
11
A
SER
33
-171.30
30.01
11
A
SER
35
-77.05
48.30
11
A
PRO
42
-49.03
105.46
11
A
CYS
44
124.68
94.62
11
A
HIS
46
-95.72
-83.76
11
A
TYR
51
-177.41
-171.74
11
A
ARG
69
75.95
-39.58
12
A
LEU
26
-92.37
-157.96
12
A
CYS
29
-103.94
58.68
12
A
SER
31
69.26
-57.58
12
A
ARG
32
69.61
-59.89
12
A
SER
33
-164.28
-167.77
12
A
GLU
38
36.15
52.32
12
A
ASP
39
-146.12
-59.33
12
A
GLN
41
98.76
138.57
12
A
HIS
46
-94.84
-92.72
12
A
ARG
69
76.00
-3.02
13
A
VAL
24
73.44
-51.48
13
A
ARG
32
-79.74
48.86
13
A
GLU
37
-43.37
106.26
13
A
ASP
39
-161.37
77.74
13
A
HIS
46
-108.25
-90.09
13
A
TYR
51
-171.56
-174.95
13
A
GLU
67
-59.52
-9.32
13
A
ARG
69
74.22
-31.65
14
A
GLU
28
34.97
39.60
14
A
CYS
29
55.63
16.21
14
A
LYS
34
-50.78
105.70
14
A
GLU
37
52.80
-97.48
14
A
ASP
39
-167.11
90.17
14
A
GLN
41
-118.68
74.87
14
A
PRO
42
-80.74
46.12
14
A
CYS
44
89.79
91.95
14
A
HIS
46
-110.15
-87.99
15
A
CYS
29
-173.03
38.39
15
A
ARG
32
-60.59
84.25
15
A
SER
33
-68.64
26.84
15
A
LYS
34
-178.70
144.40
15
A
SER
35
64.96
-65.58
15
A
GLU
38
-68.60
69.58
15
A
GLN
41
71.39
130.39
15
A
PRO
42
-52.04
98.03
15
A
HIS
46
-107.31
-70.61
15
A
GLU
67
49.93
71.16
15
A
ARG
69
66.72
63.33
15
A
HIS
70
-144.53
-36.13
16
A
SER
35
-161.37
-80.57
16
A
GLN
41
31.54
67.68
16
A
PRO
42
-71.93
-159.88
16
A
HIS
46
-111.64
-77.14
16
A
GLU
67
-57.82
-9.17
16
A
ARG
69
82.02
26.19
16
A
HIS
70
-147.65
-43.89
17
A
CYS
29
77.72
-48.89
17
A
ALA
30
-57.14
-72.60
17
A
ARG
32
-47.59
-19.71
17
A
SER
33
-154.21
58.21
17
A
LYS
34
64.87
-77.19
17
A
ASP
39
-170.15
135.03
17
A
PRO
42
-68.99
75.97
17
A
HIS
46
-106.86
-68.38
17
A
TYR
51
-174.61
-174.26
17
A
SER
58
-131.55
-55.87
17
A
CYS
59
105.03
175.07
17
A
HIS
70
-141.91
-47.05
18
A
LYS
34
92.26
68.12
18
A
HIS
46
-109.56
-87.70
18
A
TYR
51
-177.71
-176.25
18
A
ASP
68
-171.38
-17.01
18
A
ALA
74
-85.14
44.04
19
A
LEU
26
-110.20
-152.33
19
A
CYS
29
-146.48
53.62
19
A
ALA
30
76.26
-93.02
19
A
ARG
32
69.27
-63.79
19
A
SER
33
72.78
-37.36
19
A
LYS
34
-67.08
74.40
19
A
SER
35
-58.42
-80.06
19
A
GLU
37
-68.42
85.31
19
A
GLU
38
-69.15
68.16
19
A
HIS
46
-101.60
-79.02
19
A
GLU
67
69.99
-17.81
19
A
ASP
68
75.64
-3.98
19
A
HIS
70
-164.25
-47.90
STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES
1
Y
N
disulf
2.077
A
CYS
29
A
SG
CYS
7
1_555
A
CYS
48
A
SG
CYS
26
1_555
disulf
2.073
A
CYS
44
A
SG
CYS
22
1_555
A
CYS
57
A
SG
CYS
35
1_555
disulf
2.074
A
CYS
59
A
SG
CYS
37
1_555
A
CYS
72
A
SG
CYS
50
1_555
COMPLEMENT
COMPLEMENT, EGF, CALCIUM BINDING, SERINE PROTEASE
C1R_HUMAN
UNP
1
1
P00736
MWLLYLLVPALFCRAGGSIPIPQKLFGEVTSPLFPKPYPNNFETTTVITVPTGYRVKLVFQQFDLEPSEGCFYDYVKISA
DKKSLGRFCGQLGSPLGNPPGKKEFMSQGNKMLLTFHTDFSNEENGTIMFYKGFLAYYQAVDLDECASRSKSGEEDPQPQ
CQHLCHNYVGGYFCSCRPGYELQEDRHSCQAECSSELYTEASGYISSLEYPRSYPPDLRCNYSIRVERGLTLHLKFLEPF
DIDDHQQVHCPYDQLQIYANGKNIGEFCGKQRPPDLDTSSNAVDLLFFTDESGDSRGWKLRYTTEIIKCPQPKTLDEFTI
IQNLQPQYQFRDYFIATCKQGYQLIEGNQVLHSFTAVCQDDGTWHRAMPRCKIKDCGQPRNLPNGDFRYTTTMGVNTYKA
RIQYYCHEPYYKMQTRAGSRESEQGVYTCTAQGIWKNEQKGEKIPRCLPVCGKPVNPVEQRQRIIGGQKAKMGNFPWQVF
TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIAL
LELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCA
GHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTKVLNYVDWIKKEMEEED
140
192
1APQ
23
75
P00736
A
1
1
53
2
anti-parallel
A
LEU
47
A
LEU
25
A
TYR
51
A
TYR
29
A
GLY
54
A
GLY
32
A
SER
58
A
SER
36
PROBABLE CALCIUM BINDING SITE.
Unknown
5
A
ASP
25
A
ASP
3
5
1_555
A
LEU
26
A
LEU
4
5
1_555
A
GLU
28
A
GLU
6
5
1_555
A
ASN
50
A
ASN
28
5
1_555
A
TYR
51
A
TYR
29
5
1_555
1
P 1